Related Experiment Video
Updated: Jul 18, 2025
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Systems biology based miRNA-mRNA expression pattern analysis of Emodin in breast cancer cell lines
Elif Sakalli-Tecim1, Bala Gur-Dedeoglu2, N Tulin Guray3
1Department of Biotechnology, Middle East Technical University, Ankara, Turkiye.
Abstract:
Breast cancer has been among the most prominent cancers with high mortality. Currently most of the offered therapeutics are toxic; hence, less toxic therapeutic intervention is required. Here, we studied the molecular mechanisms of the effect of a phytoestrogen Emodin on estrogen receptor positive MCF-7 and negative MDA-MB-231 cells by carrying out a comprehensive network assessment. Differentially expressed microRNAs along with their previously identified differentially expressed mRNAs were analyzed through microarrays by using integrative systems biology approach. For each cell line miRNA-target gene networks were built, gene ontology and pathway enrichment analyses were performed, enrichment maps were constructed and the potential key genes, miRNAs and miRNA-gene interactions were studied.
Insights
Emodin, a plant-derived compound, shows potential as a less toxic breast cancer therapy. This study explored its molecular effects on estrogen receptor-positive and negative breast cancer cells using network analysis.
Area of Science:
- Molecular biology
- Systems biology
- Oncology
Background:
- Breast cancer is a leading cause of cancer mortality.
- Current breast cancer therapeutics often exhibit significant toxicity.
- There is a critical need for novel, less toxic therapeutic interventions.
Purpose of the Study:
- To investigate the molecular mechanisms of Emodin, a phytoestrogen, on breast cancer cells.
- To assess Emodin's effects on estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) cell lines.
- To perform a comprehensive network assessment for identifying key molecular players.
Main Methods:
- Utilized microarrays to analyze differentially expressed microRNAs and messenger RNAs (mRNAs).
- Employed an integrative systems biology approach to construct miRNA-target gene networks for each cell line.
- Conducted gene ontology and pathway enrichment analyses, including the construction of enrichment maps.
Main Results:
- Identified differentially expressed microRNAs and mRNAs in response to Emodin treatment.
- Constructed and analyzed miRNA-target gene networks specific to MCF-7 and MDA-MB-231 cells.
- Determined potential key genes, microRNAs, and their interactions involved in Emodin's mechanism of action.
Conclusions:
- Emodin exhibits distinct molecular effects on different breast cancer subtypes.
- Network-based analysis provides insights into the therapeutic potential of Emodin.
- Further research into Emodin-based therapies could lead to novel, less toxic breast cancer treatments.
